Latest news
BridgeBio Pharma Inc. R (2CL.DU) Q1 FY2025 earnings call transcript - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 07:44:20 GMTBBIO Looks 45.9% Undervalued on GF Value™ but Faces Price-to-Sal - GuruFocusGuruFocus · Sun, 09 Aug 2026 22:37:47 GMTHas BridgeBio Pharma (BBIO) Run Too Far Ahead Of Its Valuation Narrative? - simplywall.stsimplywall.st · Sun, 09 Aug 2026 04:06:32 GMTBridgeBio Oncology Therapeutics, Inc. Stock 12‑Month Price Target Cut to $24.89, Implies 167% Upside - TradingViewTradingView · Sat, 08 Aug 2026 20:20:06 GMTFARALLON CAPITAL MANAGEMENT LLC Adds to BridgeBio Pharma Inc (BB - GuruFocusGuruFocus · Sat, 08 Aug 2026 08:27:48 GMTBridgeBio Pharma Inc. R (2CL.MU) Q1 FY2026 earnings call transcript - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 22:45:44 GMTBBIO Stock Price Prediction 2025-2026 | BridgeBio Pharma Inc Forecast - 24/7 Wall St.24/7 Wall St. · Fri, 07 Aug 2026 18:12:34 GMTWill FDA Review of Encaleret and New Shelf Capacity Change BridgeBio Pharma's (BBIO) Narrative? - SahmSahm · Thu, 06 Aug 2026 07:00:00 GMT